NO20021335L - C-peptid for forbedret fremstilling av insulin og insulinanaloger - Google Patents

C-peptid for forbedret fremstilling av insulin og insulinanaloger

Info

Publication number: NO20021335L
Authority: NO; Norway
Prior art keywords: insulin; chain; amino acid; human insulin; peptide
Prior art date: 1999-10-02

Application number

NO20021335A

Other languages

English (en)

Other versions

NO329975B1 (no

NO20021335D0 (no

Inventor

Paul Habermann

Johann Ertl

Johannes Meiwes

Gerhard Seipke

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-02

Filing date

2002-03-18

Publication date

2002-06-03

2002-03-18 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2002-03-18 Publication of NO20021335D0 publication Critical patent/NO20021335D0/no

2002-06-03 Publication of NO20021335L publication Critical patent/NO20021335L/no

2011-01-31 Publication of NO329975B1 publication Critical patent/NO329975B1/no

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 5
238000004519 manufacturing process Methods 0.000 title abstract 2
VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 title 1
108010075254 C-Peptide Proteins 0.000 title 1
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 4
150000001413 amino acids Chemical group 0.000 abstract 4
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 4
239000002243 precursor Substances 0.000 abstract 3
239000004026 insulin derivative Substances 0.000 abstract 2
101100379079 Emericella variicolor andA gene Proteins 0.000 abstract 1
238000007792 addition Methods 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
230000004927 fusion Effects 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20021335A 1999-10-02 2002-03-18 H-insulinforloper eller insulinanalogforloper, DNA, vektor, vertcelle, fremgangsmate for fremstilling samt anvendelse. NO329975B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19947456A DE19947456A1 (de)	1999-10-02	1999-10-02	C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
PCT/EP2000/009017 WO2001025278A1 (de)	1999-10-02	2000-09-15	C-peptid zur verbesserten herstellung von insulin und insulinanaloga

Publications (3)

Publication Number	Publication Date
NO20021335D0 NO20021335D0 (no)	2002-03-18
NO20021335L true NO20021335L (no)	2002-06-03
NO329975B1 NO329975B1 (no)	2011-01-31

Family

ID=7924253

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021335A NO329975B1 (no)	1999-10-02	2002-03-18	H-insulinforloper eller insulinanalogforloper, DNA, vektor, vertcelle, fremgangsmate for fremstilling samt anvendelse.

Country Status (25)

Country	Link
US (1)	US6534288B1 (no)
EP (1)	EP1222207B1 (no)
JP (1)	JP4681784B2 (no)
KR (1)	KR100823463B1 (no)
CN (1)	CN1193042C (no)
AT (1)	ATE380196T1 (no)
AU (1)	AU778369B2 (no)
BR (2)	BRPI0014464B8 (no)
CA (1)	CA2385857C (no)
CY (1)	CY1107860T1 (no)
DE (2)	DE19947456A1 (no)
DK (1)	DK1222207T3 (no)
ES (1)	ES2295054T3 (no)
HK (1)	HK1049016B (no)
HU (1)	HU228313B1 (no)
IL (2)	IL148942A0 (no)
MX (1)	MXPA02003103A (no)
NO (1)	NO329975B1 (no)
NZ (1)	NZ518066A (no)
PL (1)	PL203195B1 (no)
PT (1)	PT1222207E (no)
SI (1)	SI1222207T1 (no)
TW (1)	TWI265168B (no)
WO (1)	WO2001025278A1 (no)
ZA (1)	ZA200202520B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7176278B2 (en)	2001-08-30	2007-02-13	Biorexis Technology, Inc.	Modified transferrin fusion proteins
US20050250676A1 (en) *	2001-11-19	2005-11-10	Aventis Pharma Deutschland Gmbh	Method of activating insulin receptor substrate-2 to stimulate insulin production
US20040038864A1 (en) *	2002-06-27	2004-02-26	Per Balschmidt	Use of dimethyl sulfone as isotonicity agent
DE10235168A1 (de)	2002-08-01	2004-02-12	Aventis Pharma Deutschland Gmbh	Verfahren zur Reinigung von Preproinsulin
ES2369895T3 (es) *	2003-12-03	2011-12-07	Novo Nordisk A/S	Insulina monocatenaria.
CN1663960B (zh) *	2004-03-01	2012-07-04	重庆富进生物医药有限公司	高效表达重组人胰岛素原及其类似物的新型c肽
WO2007121318A2 (en) *	2006-04-12	2007-10-25	Emisphere Technologies, Inc.	Formulations for delivering insulin
DE102008025007A1 (de)	2008-05-24	2009-11-26	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
RU2524423C2 (ru)	2008-01-09	2014-07-27	Санофи-Авентис Дойчланд Гмбх	Новые производные инсулина с чрезвычайно замедленным профилем время/действие
DE102008003568A1 (de)	2008-01-09	2009-07-16	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008025008A1 (de)	2008-05-24	2009-11-26	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008003566A1 (de)	2008-01-09	2009-07-16	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
KR20100111683A (ko) *	2008-01-09	2010-10-15	사노피-아벤티스 도이칠란트 게엠베하	극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체
PT3228320T (pt)	2008-10-17	2020-03-26	Sanofi Aventis Deutschland	Combinação de uma insulina e de um agonista do glp-1
PH12011502708B1 (en)	2009-07-06	2017-11-10	Sanofi Aventis Deutschland	Insulin preparations containing methionine
JP5832439B2 (ja)	2009-11-13	2015-12-16	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	Ｇｌｐ−１アゴニスト、インスリン及びメチオニンを含む薬学的組成物
SG10201500871TA (en)	2009-11-13	2015-04-29	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist and methionine
CN103179978A (zh)	2010-08-30	2013-06-26	赛诺菲-安万特德国有限公司	Ave0010用于制造供治疗2型糖尿病用的药物的用途
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja)	2011-08-29	2018-08-01	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	２型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI780236B (zh)	2013-02-04	2022-10-11	法商賽諾菲公司	胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
KR20160104726A (ko)	2014-01-09	2016-09-05	사노피	인슐린 유사체 및/또는 인슐린 유도체의 안정화된 무글리세롤 약제학적 제형
JP6641280B2 (ja)	2014-01-09	2020-02-05	サノフイＳａｎｏｆｉ	インスリンアナログおよび／またはインスリン誘導体の安定化された医薬製剤
CA2932873A1 (en)	2014-01-09	2015-07-16	Sanofi	Stabilized pharmaceutical formulations of insulin aspart
CN107206058A (zh)	2014-12-12	2017-09-26	赛诺菲-安万特德国有限公司	甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
WO2025099208A1 (en)	2023-11-10	2025-05-15	Intervet International B.V.	Recombinant insulin precursor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH16156A (en) *	1980-03-27	1983-07-18	Lilly Co Eli	Process for producing an insulin precursor
US4430266A (en) *	1980-11-28	1984-02-07	Eli Lilly And Company	Process for producing an insulin precursor
HRP940432B1 (en) *	1994-08-05	2003-10-31	Pliva Pharm & Chem Works	Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
PT821006E (pt) *	1996-07-26	2004-09-30	Aventis Pharma Gmbh	Derivados de insulina com ligacao a zinco aumentada
DE19726167B4 (de) *	1997-06-20	2008-01-24	Sanofi-Aventis Deutschland Gmbh	Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung

1999
- 1999-10-02 DE DE19947456A patent/DE19947456A1/de not_active Withdrawn
2000
- 2000-09-15 NZ NZ518066A patent/NZ518066A/en not_active IP Right Cessation
- 2000-09-15 PL PL354078A patent/PL203195B1/pl unknown
- 2000-09-15 KR KR1020027004275A patent/KR100823463B1/ko not_active Expired - Lifetime
- 2000-09-15 IL IL14894200A patent/IL148942A0/xx unknown
- 2000-09-15 CN CNB008137137A patent/CN1193042C/zh not_active Expired - Lifetime
- 2000-09-15 AU AU72877/00A patent/AU778369B2/en not_active Expired
- 2000-09-15 HU HU0202755A patent/HU228313B1/hu unknown
- 2000-09-15 HK HK03101211.8A patent/HK1049016B/zh not_active IP Right Cessation
- 2000-09-15 DK DK00960664T patent/DK1222207T3/da active
- 2000-09-15 AT AT00960664T patent/ATE380196T1/de active
- 2000-09-15 DE DE50014830T patent/DE50014830D1/de not_active Expired - Lifetime
- 2000-09-15 BR BRPI0014464A patent/BRPI0014464B8/pt unknown
- 2000-09-15 MX MXPA02003103A patent/MXPA02003103A/es active IP Right Grant
- 2000-09-15 ES ES00960664T patent/ES2295054T3/es not_active Expired - Lifetime
- 2000-09-15 WO PCT/EP2000/009017 patent/WO2001025278A1/de not_active Ceased
- 2000-09-15 JP JP2001528218A patent/JP4681784B2/ja not_active Expired - Lifetime
- 2000-09-15 BR BR0014464-9A patent/BR0014464A/pt not_active IP Right Cessation
- 2000-09-15 PT PT00960664T patent/PT1222207E/pt unknown
- 2000-09-15 EP EP00960664A patent/EP1222207B1/de not_active Expired - Lifetime
- 2000-09-15 SI SI200030981T patent/SI1222207T1/sl unknown
- 2000-09-15 CA CA2385857A patent/CA2385857C/en not_active Expired - Lifetime
- 2000-09-29 TW TW089120149A patent/TWI265168B/zh not_active IP Right Cessation
- 2000-10-02 US US09/676,787 patent/US6534288B1/en not_active Expired - Lifetime
2002
- 2002-03-18 NO NO20021335A patent/NO329975B1/no not_active IP Right Cessation
- 2002-03-28 ZA ZA200202520A patent/ZA200202520B/xx unknown
- 2002-03-31 IL IL148942A patent/IL148942A/en active IP Right Grant
2008
- 2008-01-18 CY CY20081100078T patent/CY1107860T1/el unknown

Also Published As

Publication number	Publication date
PL203195B1 (pl)	2009-09-30
HK1049016A1 (en)	2003-04-25
JP2003511018A (ja)	2003-03-25
AU778369B2 (en)	2004-12-02
HU228313B1 (en)	2013-03-28
NO329975B1 (no)	2011-01-31
JP4681784B2 (ja)	2011-05-11
CN1193042C (zh)	2005-03-16
MXPA02003103A (es)	2002-09-30
SI1222207T1 (sl)	2008-04-30
CA2385857A1 (en)	2001-04-12
KR20020047209A (ko)	2002-06-21
DE50014830D1 (de)	2008-01-17
BRPI0014464B8 (pt)	2021-05-25
BRPI0014464B1 (pt)	2018-03-13
HK1049016B (zh)	2005-10-14
ES2295054T3 (es)	2008-04-16
AU7287700A (en)	2001-05-10
NO20021335D0 (no)	2002-03-18
EP1222207A1 (de)	2002-07-17
IL148942A0 (en)	2002-09-12
WO2001025278A1 (de)	2001-04-12
PT1222207E (pt)	2008-02-11
KR100823463B1 (ko)	2008-04-21
PL354078A1 (en)	2003-12-15
CY1107860T1 (el)	2013-06-19
IL148942A (en)	2010-02-17
ZA200202520B (en)	2002-12-24
DE19947456A1 (de)	2001-04-05
CA2385857C (en)	2012-05-22
CN1377370A (zh)	2002-10-30
NZ518066A (en)	2004-05-28
HUP0202755A2 (hu)	2002-12-28
BR0014464A (pt)	2002-06-11
ATE380196T1 (de)	2007-12-15
EP1222207B1 (de)	2007-12-05
HUP0202755A3 (en)	2005-01-28
US6534288B1 (en)	2003-03-18
DK1222207T3 (da)	2008-03-17
TWI265168B (en)	2006-11-01

Legal Events

Date	Code	Title	Description
2020-10-12	MK1K	Patent expired

Publication	Publication Date	Title
NO20021335D0 (no)	2002-03-18	C-peptid for forbedret fremstilling av insulin og insulinanaloger
ATE124997T1 (de)	1995-07-15	Enzymatische entfernung einer aminoterminalen proteinsequenz.
HUP9801886A2 (hu)	1999-01-28	Eljárás megfelelően kapcsolódó cisztinhidakat tartalmazó inzulin-prekurzorok előállítására
EA200000748A1 (ru)	2000-12-25	Способ введения мономерных аналогов инсулина
ATE443082T1 (de)	2009-10-15	Insulinvorstufen und verfahren zu deren herstellung
CY1107398T1 (el)	2012-12-19	Νεα διφαινυλαζητιδoνη με βελτιωμενες φυσιολογικες ιδιοτητες, η διαδικασια για την παραγωγη της, το φαρμακευτικο παρασκευασμα που περιεχει τις ενωσεις αυτες καθως και η χρηση του
EP0262399A3 (en)	1989-04-26	Cyclic enol derivatives, production and use thereof
HUP0100928A2 (hu)	2001-08-28	Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
DE69938064D1 (de)	2008-03-13	Aminoterminal modifizierte parathyroidhormon (pth) analoge
PT1497289E (pt)	2005-11-30	Farmaco contendo betamimeticos e um novo anticolinergico
DK1439830T3 (da)	2006-02-13	Farmaceutisk præparat med 2-(4-isobutylphenyl)propionsyre
IL152348A0 (en)	2003-05-29	Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
ATE474930T1 (de)	2010-08-15	Verfahren zur herstellung von insulinvorläufern und analogen von insulinvorläufern mit verbesserter fermentationsausbeute in hefe
DE3873578D1 (de)	1992-09-17	Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ITRM20000340A0 (it)	2000-06-23	Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie cara
TR200101083T2 (tr)	2001-08-21	(7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
WO2001064715A3 (en)	2002-03-21	Memno peptides, a process for their preparation and their use
SE0201938D0 (sv)	2002-06-20	New process
HU208704B (en)	1993-12-28	Process for producing insuline precurzor
SU1701705A1 (ru)	1991-12-30	Высокопрочный керамический материал
JPS55164668A (en)	1980-12-22	Alpha-amino-beta-chloroethane-sulfonic acid or its salt
YU63402A (sh)	2005-11-28	Memno peptidi, postupak za njihovo pripremanje i njihova primena
ATE114307T1 (de)	1994-12-15	Phenylglycidamide, verwendbar in der herstellung von alpha-hydroxy-beta-sulfido-arylpropionsäure- derivaten.
IT8920337A0 (it)	1989-04-28	Procedimento per la preparazione dell'acido 3 idrossi 3 metil glutarico mediante ossidazione con ipoclorito del 3 metil 1,3,5 pentantriolo.